1. Home
  2. NLOP vs SGHT Comparison

NLOP vs SGHT Comparison

Compare NLOP & SGHT Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

NLOP

Net Lease Office Properties of Beneficial Interest

HOLD

Current Price

$11.70

Market Cap

198.4M

Sector

N/A

ML Signal

HOLD

Logo Sight Sciences Inc.

SGHT

Sight Sciences Inc.

HOLD

Current Price

$3.50

Market Cap

187.4M

Sector

Health Care

ML Signal

HOLD

Company Overview

Basic Information
Metric
NLOP
SGHT
Founded
N/A
2011
Country
United States
United States
Employees
N/A
N/A
Industry
Medical Specialities
Sector
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
198.4M
187.4M
IPO Year
2022
2021

Fundamental Metrics

Financial Performance
Metric
NLOP
SGHT
Price
$11.70
$3.50
Analyst Decision
Buy
Analyst Count
0
7
Target Price
N/A
$9.08
AVG Volume (30 Days)
197.1K
356.1K
Earning Date
05-19-2026
05-07-2026
Dividend Yield
57.30%
N/A
EPS Growth
N/A
28.16
EPS
N/A
N/A
Revenue
$118,915,000.00
$77,363,000.00
Revenue This Year
N/A
$11.67
Revenue Next Year
N/A
$10.39
P/E Ratio
N/A
N/A
Revenue Growth
N/A
N/A
52 Week Low
$11.24
$2.03
52 Week High
$34.53
$9.24

Technical Indicators

Market Signals
Indicator
NLOP
SGHT
Relative Strength Index (RSI) 29.83 35.68
Support Level N/A $3.29
Resistance Level $14.95 $3.76
Average True Range (ATR) 0.39 0.22
MACD -0.13 0.06
Stochastic Oscillator 13.78 15.71

Price Performance

Historical Comparison
NLOP
SGHT

About NLOP Net Lease Office Properties of Beneficial Interest

Net Lease Office Properties is a Maryland real estate investment trust that, together with its consolidated subsidiaries, owns a diversified portfolio of office properties that are primarily leased to corporate tenants on a single-tenant, net-lease basis. Its net leases generally specify a base rent with rent increases and require the tenant to pay substantially all costs associated with operating and maintaining the property. Its portfolio includes approximately 1.2 million square feet of Green-Certified Buildings, 2 LEED-certified buildings, and 1 BREEAM-certified building.

About SGHT Sight Sciences Inc.

Sight Sciences Inc is an ophthalmic medical device company focused on the development and commercialization of surgical and nonsurgical technologies for the treatment of prevalent eye diseases. The company operates through two segments: Interventional Glaucoma, which generates the majority of revenue and includes the OMNI Surgical System family of products and the SION Surgical Instrument used in minimally invasive glaucoma surgery to reduce intraocular pressure in adult patients with open-angle glaucoma; and Interventional Dry Eye, which includes the TearCare System, an interventional device designed to melt and facilitate the removal of meibomian gland obstructions and restore gland functionality in adult patients with evaporative dry eye disease.

Share on Social Networks: